Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Orphan diseases

  • Treatment failure of nontuberculosis pulmonary disease after adjunctive surgical resection
    Noeul Kang, Byung Woo Jhun
    European Respiratory Journal Sep 2021, 58 (suppl 65) OA1602; DOI: 10.1183/13993003.congress-2021.OA1602
  • The long-term outcome of adult pulmonary Langerhans cell histiocytosis: a national registry-based prospective cohort study
    Amira Benattia, Emmanuelle Bugnet, Anouk Walter-Petrich, Gwenaël Lorillon, Sylvie Chevret, Abdellatif Tazi
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5252; DOI: 10.1183/13993003.congress-2020.5252
  • Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial
    Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L. F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4578; DOI: 10.1183/13993003.congress-2020.4578
  • Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentric retrospective cohort study
    Quentin Philippot, Caroline Kannengiesser, Ibrahima Ba, Anne Gondouin, Jean-Marc Naccache, Martine Reynaud-Gobert, Yurdagul Uzunhan, Benjamin Bondue, Dominique Israel Biet, Effrosyne Manali, Spyros Papiris, Lidwine Wemeau, Sandrine Hirschi, Hervé Mal, Hilario Nunes, Frédéric Schlemmer, Matthieu Rigaud, Vincent Cottin, Bruno Crestani, Raphaël Borie
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5254; DOI: 10.1183/13993003.congress-2020.5254
  • Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial
    Claudia Valenzuela, Toby M Maher, Francesco Bonella, Alberto Pesci, Stephane Jouneau, Nina M Patel, Evans R Fernández Pérez, Rainer-Georg Goeldner, Susanne Stowasser, Rozsa Schlenker-Herceg, Manuel Quaresma, Vincent Cottin
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4577; DOI: 10.1183/13993003.congress-2020.4577
  • Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium
    Danielle Strens, Benjamin Bondue, Caroline Dahlqvist, Hans Slabbynk, Julien Guiot, Guy F. Joos, Natacha Gusbin, Wim Janssens, Antoine Froidure, Wim Wuyts
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4810; DOI: 10.1183/13993003.congress-2020.4810
  • Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases
    Diego Castillo Villegas, Silvia Barril Farre, Paloma Millan Billi, Oriol Sibila Vidal, Alfonso Luque, Paloma Acebo, Sonsoles Hortelano Blanco
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5253; DOI: 10.1183/13993003.congress-2020.5253
  • Does nintedanib have the same effect on FVC decline in patients with progressive fibrosing ILDs treated with DMARDs or glucocorticoids?
    Nazia Chaudhuri, Vincent Cottin, Stefania Cerri, Michael Kreuter, Maria Otaola, Diego Castillo Villegas, Craig Glazer, Heiko Müller, Carl Coeck, Manuel Quaresma, Toby M Maher
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4576; DOI: 10.1183/13993003.congress-2020.4576
  • Identification and characterisation of twenty-two novel SERPINA1 pathological mutations
    Stefania Ottaviani, Anna Maria Fra, Alice Maria Balderacchi, Valentina Barzon, Tomas Patrick Carroll, Davide Piloni, Francesca Mariani, Noel Gerard Mc Elvaney, Angelo Guido Corsico, Ilaria Ferrarotti
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4922; DOI: 10.1183/13993003.congress-2020.4922
  • Fibrosing cases of chronic eosinophilic pneumonia
    Naoko Takeuchi, Toru Arai, Kazunobu Tachibana, Takayuki Takimoto, Yoshinobu Matsuda, Yu Kurahara, Kanako Katayama, Yukihiro Nakamura, Reiko Sugawara, Chikatoshi Sugimoto, Seiji Hayashi, Masanori Akira, Takahiko Kasai, Yoshikazu Inoue
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3480; DOI: 10.1183/13993003.congress-2020.3480

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 21
  • Acute lung injury and critical care (82)
  • Asthma and allergy (632)
  • CF and non-CF bronchiectasis (270)
  • COPD and smoking (901)
  • Epidemiology, occupational and environmental lung disease (212)
  • Genetics (58)
  • Interstitial and orphan lung disease (484)
  • Lung biology and experimental studies (305)
  • Lung cancer (275)
  • Lung imaging (40)
  • Lung structure and function (302)
  • Mechanisms of lung disease (144)
  • Paediatric pulmonology (391)
  • Pulmonary pharmacology and therapeutics (140)
  • Pulmonary vascular disease (505)
  • Respiratory clinical practice (166)
  • Respiratory infections and tuberculosis (943)
  • Sleep medicine (263)
  • Most Read
  • Twitter
Loading
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Pulsus paradoxus
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
  • ERS clinical practice guidelines on treatment of sarcoidosis
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society